← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dana-Farber Cancer Institute
Boston, MA
$463,760,380
Total funding
638
Grants
Funding over time
peak $128.6M · FY2005–24$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$473,982,030 · 620
NSF$16,652,861 · 16
AHRQ$0 · 1
CDC$0 · 4
FDA$0 · 1
By mechanism
R01$234,194,298 · 206
P01$52,412,293 · 107
U01$27,986,369 · 15
R37$24,047,501 · 12
U10$18,017,263 · 3
P30$16,996,268 · 36
Investigators at Dana-Farber Cancer Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
CANCER CENTER SUPPORT GRANT$10,370,763
P30 · FY2004 · CA
CANCER CENTER SUPPORT GRANT$10,177,931
P30 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$10,170,651
P30 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$10,117,597
P30 · FY2002 · CA
CANCER CENTER SUPPORT GRANT$9,266,161
P30 · FY2000 · CA
A Plant Interactome Network Map$7,971,396
· FY2007 · BIO
CANCER CENTER SUPPORT GRANT$4,321,151
P30 · FY2005 · CA
Rebuilding Immunity for Survival$3,651,182
P01 · FY2005 · CA
Rebuilding Immunity for Survival$3,500,000
P01 · FY2003 · CA
Orthopox immunization in patients with cancer or eczema$3,422,012
U19 · FY2005 · AI
Orthopox immunization in patients with cancer or eczema$3,360,940
U19 · FY2004 · AI
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,307,331
P01 · FY2004 · CA
DANA-FARBER/HARVARD SPORE IN BREAST CANCER$3,296,117
P50 · FY2002 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$3,285,136
P01 · FY2005 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,219,060
P01 · FY2003 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$3,197,290
P01 · FY2004 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$3,109,897
P01 · FY2003 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,067,890
P01 · FY2002 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,000,757
P01 · FY2001 · CA
Molecular Targets of Germinal Center B Cell Lymphomas$2,976,629
P01 · FY2002 · CA